Abstract

The interactions between reactive oxygen species (ROS) production and kidney nephropathy in metabolic syndrome are not well described. This study assessed the effects of blocking 1) renin‐angiotensin system (RAS), 2) tumor necrosis factor‐alpha (TNFα)‐mediated inflammation, 3) and non‐RAS‐mediated hypertension on the activity of the antioxidant enzymes, glutathione peroxidase (GPx), catalase (CAT), and superoxide dismutase (SOD) in the kidney of insulin resistant (IR), Otsuka‐Long‐Evans‐Tokushima‐Fatty (OLETF) rats. Lean and obese rats (n = 5‐7/group) were randomly assigned to the following groups: 1) untreated Long‐Evans‐Tokushima‐Otsuka (LETO) (lean, strain control ), 2) untreated OLETF, 3) OLETF + angiotensin receptor blocker (ARB) (10 mg olmesartan/kg/d x 10 wk), 4) OLETF + TNFα blocker (ETAN) (1.25 mg entanercept/kg/d x 10 wk), 5) OLETF + calcium channel blocker (CCB) (3 mg amlodipine/kg/d x 10 wk), and 6) OLETF + ARB+ ETAN (COMBO) (same doses x 10 wk). OLETF exhibited a 23% decrease (41 ± 4 vs. 32 ± 3 nmol/min/ml) in mean GPx activity. TNFα blockade completely recovered the IR‐associated decrease in GPx activity (45 ± 4 nmol/min/ml) demonstrating that TNFα contributes to the dysregulation of antioxidant enzymes in the IR kidney. Catalase and SOD activities, while elevated, were not different among groups suggesting that the dysregulation of antioxidant enzymes is selective during IR conditions.Grant Funding Source: APS Teacher Researcher

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.